PNC Financial Services Group
NRIX icon

PNC Financial Services Group’s Nurix Therapeutics NRIX Stock Holding History

PNC Financial Services Group’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.97K Hold
450
– – ﹤0.01% 4119
2025
Q4 		$8.54K Buy
450
+10
+2% +$144 ﹤0.01% 4030
2025
Q3 		$4.07K Buy
440
+310
+238% +$3.22K ﹤0.01% 4292
2025
Q2 		$1.48K Buy
130
+76
+141% +$821 ﹤0.01% 4491
2025
Q1 		$642 Buy
54
+37
+218% +$619 ﹤0.01% 4589
2024
Q4 		$320 Hold
17
– – ﹤0.01% 4593
2024
Q3 		$382 Hold
17
– – ﹤0.01% 4599
2024
Q2 		$355 Buy
17
+13
+325% +$202 ﹤0.01% 4581
2024
Q1 		$59 Buy
+4
New +$43 ﹤0.01% 4661

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

PNC Financial Services Group's NRIX Position: Q1 2026 in Review

PNC Financial Services Group held its Nurix Therapeutics (NRIX) position steady in Q1 2026 at 450 shares worth $6.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4119.

PNC Financial Services Group first reported a position in NRIX in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.54K in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • PNC Financial Services Group held 450 shares of Nurix Therapeutics worth $6.97K as of Q1 2026.
  • PNC Financial Services Group left its Nurix Therapeutics share count unchanged in Q1 2026.
  • Nurix Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4119 holding.
  • PNC Financial Services Group first reported a position in Nurix Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • PNC Financial Services Group's Nurix Therapeutics position peaked at $8.54K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.